Following our recent reports that human cystatin B, β-2-microglobulin and cytidine monophosphate kinase are ovarian tumour progression markers and are regulated by TGF-β129–31, we speculate that PNPO may be another EOC biomarker and that it may also be regulated by TGF-β signalling. Here, PNPO is linked to ovarian neoplasm.